How Far Should We Investigate Diffuse Alopecia in Women?

    Claire Dupont
    Image of study
    TLDR Routine thyroid tests for diffuse alopecia in women may not be necessary, but checking for iron deficiency anemia could be useful.
    The document discusses the investigation of diffuse alopecia in women, a condition often without a clear cause but commonly considered a form of androgenic alopecia. The study assessed 50 female patients with diffuse alopecia, aged 16 to 69, with symptoms lasting from 3 months to 30 years. Routine thyroid function tests and full blood counts were conducted, with all results normal except for one patient with iron deficiency anemia due to menorrhagia. The conclusion suggests that thyroid tests may not be routinely warranted unless clinical signs support it, but a full blood count may be worthwhile as iron deficiency anemia could have a causal role in some cases of alopecia. The document also includes a separate study on the effects of calcipotriol, a topical treatment for psoriasis, on systemic calcium homeostasis, concluding that a single application of 6g does not have an acute effect on systemic calcium levels.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results
      Acquired Scalp Alopecia: A Review

      research Acquired Scalp Alopecia: A Review

      44 citations, November 1998 in “Australasian Journal of Dermatology”
      Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.
      Telogen Effluvium: A Review of Acute and Chronic Forms

      research Telogen Effluvium: A Review of Acute and Chronic Forms

      67 citations, January 2013 in “Indian Journal of Dermatology, Venereology and Leprology”
      Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.
      Hair Loss and Hedgehog Inhibitors: A Class Effect?

      research Hair Loss and Hedgehog Inhibitors: A Class Effect?

      9 citations, December 2014 in “British Journal of Dermatology”
      Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.
      Evaluation of Hair Loss

      research Evaluation of Hair Loss

      21 citations, May 1996 in “Current problems in dermatology”
      Detailed patient history and physical exams are crucial for diagnosing hair loss.